As an example, in BRCA2 mutant high-grade serous ovarian cancer PDX cells, the combinations of PARPi with ATRi or CHKi were synergistic and caused tumor growth suppression and in some cases complete remission32. The gene discussed is BRCA2; the disease is ovarian serous adenocarcinoma.